Maxcyte (MXCT) EBITDA Margin (QoQ) (2020 - 2026)
Maxcyte (MXCT) EBITDA Margin (QoQ) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.37 Bn | 193.76 Bn | 7.27 Bn |
| 2 | Stryker | 127.75 Bn | 124.27 Bn | 4.50 Bn |
| 3 | Medtronic | 119.07 Bn | 109.85 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.39 Bn | 72.85 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.90 Bn | 47.64 Bn | 1.35 Bn |
| 6 | Dexcom | 34.36 Bn | 32.41 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.90 Bn | 31.79 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.38 Bn | 23.06 Bn | 4.55 Bn |
| 9 | Steris | 23.04 Bn | 22.56 Bn | 684.20 Mn |
| 10 | Maxcyte | 147.42 Mn | 147.42 Mn | 5.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -7,664.00 |
| Mar 31, 2026 | -37,281.00 |
| Dec 31, 2025 | 44,259.00 |
| Sep 30, 2025 | -3,995.00 |
| Jun 30, 2025 | -4,890.00 |
| Mar 31, 2025 | 9,473.00 |
| Dec 31, 2024 | -4,093.00 |
| Sep 30, 2024 | 6,896.00 |
| Jun 30, 2024 | -2,127.00 |
| Mar 31, 2024 | -18,933.00 |
| Dec 31, 2023 | 30,521.00 |
| Sep 30, 2023 | -19,114.00 |
| Jun 30, 2023 | 12,091.00 |
| Mar 31, 2023 | -17,844.00 |
| Dec 31, 2022 | -1,457.00 |
| Sep 30, 2022 | 1,849.00 |
| Jun 30, 2022 | -5,506.00 |
| Mar 31, 2022 | 3,013.00 |
| Dec 31, 2021 | -4,193.00 |
| Sep 30, 2021 | 3,805.00 |